A股異動 | 金髮拉比(002762.SZ)喜提六連板 2.37億入股廣東韓妃醫院
格隆匯4月12日丨金髮拉比(002762.SZ)連續第六日一字漲停,報10.79元,股價創近三年半新高,總市值38億元。近日,金髮拉比發佈《關於投資廣東韓妃醫院投資有限公司的公吿》。公吿顯示,公司將以2.37億元自有資金受讓廣東韓妃醫院的36%股權,並投資設立基金規模為3億元的醫美產業基金。真金白銀入股,金髮拉比也對廣東韓妃醫院提出了業績承諾。公吿顯示,韓妃投資2021年度和2022年度實現的歸屬母公司所有者的淨利潤(扣除非經常性損益)合計不低於人民幣1.1億元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.